QUAY STEVEN C 4
4 · ATOSSA THERAPEUTICS, INC. · Filed Apr 13, 2020
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-04-09+195,000→ 195,000 totalExercise: $1.48Exp: 2030-04-09→ Common Shares (195,000 underlying) - Award
Stock Option (Right to Buy)
2020-04-09+1,305,000→ 1,305,000 totalExercise: $1.48Exp: 2030-04-09→ Common Shares (1,305,000 underlying)
Footnotes (2)
- [F1]The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates.
- [F2]The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates. However, 50% of all then-unvested options will vest immediately upon the achievement of certain milestones. The stock options are also subject to stockholder approval of the 2020 Stock Incentive Plan of the Company, which approval must occur within one year from the grant date.